title: Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma.
authors.affiliation: Departamento de Oftalmología, Hospital Universitario y Politécnico La Fe, Valencia, España. Electronic address: pablooftalmologia@gmail.com.
authors.forename: P
authors.initials: P
authors.lastname: Hernández-Martínez
authors.affiliation: Departamento de Oftalmología, Hospital Universitario y Politécnico La Fe, Valencia, España.
authors.forename: R
authors.initials: R
authors.lastname: Gallego-Pinazo
authors.affiliation: Departamento de Cirugía, Facultad de Medicina, Universidad de Valencia, Valencia, España.
authors.forename: R
authors.initials: R
authors.lastname: Dolz-Marco
authors.affiliation: Retina Division, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, Estados Unidos; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riad, Arabia Saudí
authors.forename: J F
authors.initials: JF
authors.lastname: Arevalo
authors.affiliation: Departamento de Cirugía, Facultad de Medicina, Universidad de Valencia, Valencia, España.
authors.forename: M
authors.initials: M
authors.lastname: Díaz-Llopis
authors.affiliation: Departamento de Oftalmología, Hospital Universitario y Politécnico La Fe, Valencia, España.
authors.forename: A
authors.initials: A
authors.lastname: Cisneros Lanuza
mesh_terms: D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D018325:Hemangioblastoma / Q000150:complications*; D006801:Humans; D058449:Intravitreal Injections; D017075:Laser Coagulation; D008297:Male; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D000069579:Ranibizumab / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012163:Retinal Detachment / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D019572:Retinal Neoplasms / Q000150:complications*
chemical_list: D000319:Adrenergic beta-Antagonists; D020533:Angiogenesis Inhibitors; D011433:Propranolol; D000069579:Ranibizumab